Bloodstream Infection

LOS ANGELES — A panel of experts awarded David Roach, MD, instructor of medicine at Harvard Medical School, and his team a $5,000 grant to aid in the development of a low-cost, easy-to-use assay for bacterial bloodstream infections.

A multicenter study identified factors associated with mortality among patients with Candida auris bloodstream infection.

Researchers linked more than 1 million deaths in Africa in 2019 to antimicrobial resistance, more than half of which were linked to just four pathogens.

After assessing Klebsiella pneumoniae bloodstream infections, researchers are calling for more rapid identification methods to find patients with resistant infections because choosing the wrong first antibiotics increases mortality risk.

The real-time delivery of patient information can improve mortality rates among patients with bloodstream infections, according to a study published in Clinical Infectious Diseases.

Adults on dialysis for end-stage kidney disease are 100 times more likely to have a Staphylococcus aureus bloodstream infection than those not on dialysis, according to a new report, which uncovered disparities in the rates of infection.

Patients with ceftriaxone-resistant Escherichia coli bloodstream infections generally had worse outcomes compared with patients with ceftriaxone-susceptible E. coli infections, according to a recent study.

The 90-day crude mortality among more than 600 patients with Candida bloodstream infections at a St. Louis hospital was higher than 40%, a study found.

The incidence of vancomycin-resistant enterococci bloodstream infections significantly increased in California hospitals during the second and third quarter of 2020 compared with the same period in 2019, a report showed.

Adult patients hospitalized with severe COVID-19 and secondary bloodstream infections had a more severe initial presentation, prolonged hospital stay and worse clinical outcomes, according to a recent study.